GLP-3 (RT) Product Information
GLP-3 (RT) is a synthetically engineered tri-agonist peptide evaluated in laboratory and preclinical research settings for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor families in non-human experimental models. In controlled research environments, GLP-3 (RT) is utilized to examine multi-receptor binding characteristics, signaling pathway engagement, and receptor cross-talk within in vitro systems and non-human laboratory models. Its molecular structure supports analytical investigation of concurrent receptor interaction and signaling integration under standardized experimental conditions. GLP-3 (RT) is supplied exclusively for research and analytical use and is not intended for human consumption, diagnosis, treatment, or therapeutic application. Summary of Characteristics Characteristic Details Chemical Sequence of Amino Acids His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly with additional sequence modifications supporting tri-receptor interaction and C-terminal extensions characteristic of tri-agonist design CAS Number 2381089-83-2 Molecular Formula C225H348N48O68 Molecular Weight 4,814.52 g/mol Other Known Titles GLP-3 (RT); tri-agonist peptide (research designation)
